Literature DB >> 4735112

A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.

J P Dickinson, E A Caspary, E J Field.   

Abstract

(1) The antigenic activity of basic protein extracts of a variety of human tissues towards sensitized lymphocytes from cancer patients has been studied using the macrophage electrophoretic migration method.(2) Basic protein prepared from human tumour tissue has antigenic properties which differ from basic protein prepared from normal tissues, from hyperplastic tissue and even tumour bearing host tissue.(3) Tumour type antigenic molecules are at least 10(4) times less numerous on normal cells than on tumour cells. If our reasoning is accepted then they are absent from normal cells, and thus restricted in vivo to malignant cells.(4) Hyperplastic tissues (gynaecomastia, etc.) do not contain cancer basic protein.(5) Human chronic lymphatic leukaemic leucocytes possess the same type of cancer antigenic activity as solid tumours. This antigenic activity is not shared by normal lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4735112      PMCID: PMC2008838          DOI: 10.1038/bjc.1973.13

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Allergic encephalomyelitis: enzymatic degradation of the encephalitogenic basic protein from bovine spinal cord.

Authors:  G A Hashim; E H Eylar
Journal:  Arch Biochem Biophys       Date:  1969-02       Impact factor: 4.013

2.  Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques.

Authors:  D Hughes; E A Caspary
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

3.  Immune response to urinary bladder tumours in man.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-01-15       Impact factor: 7.396

4.  Systematic antigenic change in human carcinoma tissues by hemagglutination techniques.

Authors:  B Björklund
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

5.  Demonstration of sensitized lymphocytes in blood.

Authors:  E J Field; E A Caspary
Journal:  J Clin Pathol       Date:  1971-03       Impact factor: 3.411

6.  In vitro methods in cell-mediated immunity in man.

Authors:  B R Bloom
Journal:  N Engl J Med       Date:  1971-05-27       Impact factor: 91.245

7.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

8.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12

9.  Immunological studies on urinary bladder tumors of rats and mice.

Authors:  L A Taranger; W H Chapman; I Hellström; K E Hellström
Journal:  Science       Date:  1972-06-23       Impact factor: 47.728

10.  Recognition of leukaemia cells as foreign before and after autoimmunization.

Authors:  R L Powles; L A Balchin; G H Fairley; P Alexander
Journal:  Br Med J       Date:  1971-02-27
View more
  19 in total

1.  [The electrophoretic-mobility-test (EMT) in the diagnosis of malignancies (author's transl)].

Authors:  F R Douwes; R Hanke; K Mross
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-12-09

2.  Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.

Authors:  H L Jenssen; H Köhler; J Günther; B Klausch; W Straube; R Hofmann; H H Büttner
Journal:  Arch Gynakol       Date:  1976-03-05

3.  [Remarks to the paper of H. Meyer-Rienecker, H.-L. Jenssen, H. Köhler, J. Günther und H. J. Gundlach: Utilization and significance of the macrophages-electrophoresis-mobility (MEM)-test in neurologic diseases].

Authors:  E J Field
Journal:  Klin Wochenschr       Date:  1974-11-15

4.  [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].

Authors:  C Tautz; W Schneider; E Laier; G Brügmann
Journal:  Klin Wochenschr       Date:  1978-02-15

5.  Antigen cross-reactivity in the macrophage electrophoretic mobility test. A study using cellular affinity chromatography.

Authors:  J R McDermott; E A Caspary; J P Dickinson
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

6.  The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

Authors:  A W Preece; P A Light
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

Review 7.  Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncology.

Authors:  A M Neville; A M Mackay; J Westwood; C Turberville; D J Laurence
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

8.  Immunological cross-reactivity between basic proteins of myelin and cancer. I. Lymphocyte transformation studies in immunized guinea-pigs.

Authors:  A S Coates; P R Carnegie
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

9.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

10.  Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.

Authors:  D J Flavell; A Singer; C W Potter
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.